These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4655352)

  • 1. A study of the bradycardic effect of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678) in the anesthetized dog.
    Sherman GP
    Am J Pharm Sci Support Public Health; 1972; 144(4):110-5. PubMed ID: 4655352
    [No Abstract]   [Full Text] [Related]  

  • 2. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of the antihypertensive agent 2,6-dichlorobenzylidene amino guanidine acetate (WY-8678) on the cardiac conduction system.
    Baum T; Rowles G; Shropshire AT
    Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):75-84. PubMed ID: 5437328
    [No Abstract]   [Full Text] [Related]  

  • 4. 2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent.
    Baum T; Eckfeld DK; Metz N; Dinish JL; Rowles G; Van Pelt R; Shropshire AT; Fernandez SP; Gluckman MI; Bruce WF
    Experientia; 1969 Oct; 25(10):1066-7. PubMed ID: 5357105
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular actions of guancydine in normotensive and hypertensive animals.
    Cummings JR; Welter AN; Grace JL; Lipchuck LM
    J Pharmacol Exp Ther; 1968 May; 161(1):88-97. PubMed ID: 4296847
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678.
    Baum T; Shropshire AT
    Neuropharmacology; 1970 Sep; 9(5):503-6. PubMed ID: 4320109
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular profile of BR750 (2,6-dichloro-benzylideneamino-guanidine acetate).
    Marmo E; Saini RK; Caputi AP; Vacca C
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):391-406. PubMed ID: 4750091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological effects of a new antihypertensive agent with imidazoline structure].
    Hoefke W; Kobinger W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):28-9. PubMed ID: 4231841
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible mechanism of the hypotensive action of 2,6-dichlorobenzylidene aminoguanidine: evidence for central noradrenaline receptor stimulation.
    Bolme P; Carrodi H; Fuxe K
    Eur J Pharmacol; 1973 Aug; 23(2):175-82. PubMed ID: 4733776
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits.
    Poisson D; Christen MO; Sannajust F
    J Pharmacol Exp Ther; 2000 Jun; 293(3):929-38. PubMed ID: 10869394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular profile of BR 750 (2,6-dichlorobenzylideneaminoguanidine acetate).
    Saini RK; Caputi AP; Marmo E
    Farmaco Prat; 1973 Jul; 28(7):359-87. PubMed ID: 4724740
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of guanabenz concentrations in brain and plasma to antihypertensive effect in the spontaneously hypertensive rat.
    Meacham RH; Ruelius HW; Kick CJ; Peters JR; Kocmund SM; Sisenwine SF; Wendt RL
    J Pharmacol Exp Ther; 1980 Sep; 214(3):594-8. PubMed ID: 7400962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of guanethidine and cyclazenine on the sympathomimetic effect of cyclohexylamine].
    Classen HG
    Arzneimittelforschung; 1969 Jun; 19(6):929-32. PubMed ID: 5820405
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of 1-4-dihydrazinophthalazine on arterial pressure and heart rate, before and after administration of beta-blocking drugs].
    Campus S; Rappelli A; Fabris F; Mathis I
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1847-51. PubMed ID: 5602829
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effects of sympathomimetic amines.
    Vidrio H; Pardo EG
    J Pharmacol Exp Ther; 1973 Nov; 187(2):308-14. PubMed ID: 4748548
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood pressure and heart rate of rats after repeated treatment with 2-(2,6-dichlorphenylamino)-2-imidazoline].
    Walland A
    Arzneimittelforschung; 1968 Jul; 18(7):833-6. PubMed ID: 5755830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circulation experiments in dogs with 2-amino-6-methylheptane-(+)-camphor-10-sulfonate].
    Becker KH; Dörner J
    Arzneimittelforschung; 1967 Jan; 17(1):28-32. PubMed ID: 5632523
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.